CLEC11A and cancer: Elevated levels of SCGF-β, a variant of SCGF, have been detected in circulating tumor cells in breast cancer [10] and are linked to increased aggressiveness and metastatic potential in lung cancers originating from drug-resistant cancer stem cells marked by CD133, exhibiting increased levels of angiogenic and growth factors, including SCGF-β [11].